CDIO
Price
$3.40
Change
-$0.34 (-9.09%)
Updated
Nov 13 closing price
Capitalization
5.99M
Intraday BUY SELL Signals
RCUS
Price
$19.91
Change
+$0.13 (+0.66%)
Updated
Nov 14, 02:42 PM (EDT)
Capitalization
2.45B
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CDIO vs RCUS

Header iconCDIO vs RCUS Comparison
Open Charts CDIO vs RCUSBanner chart's image
Cardio Diagnostics Holdings
Price$3.40
Change-$0.34 (-9.09%)
Volume$18.1K
Capitalization5.99M
Arcus Biosciences
Price$19.91
Change+$0.13 (+0.66%)
Volume$100
Capitalization2.45B
CDIO vs RCUS Comparison Chart in %
View a ticker or compare two or three
VS
CDIO vs. RCUS commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIO is a StrongBuy and RCUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CDIO: $3.40 vs. RCUS: $19.79)
Brand notoriety: CDIO and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDIO: 50% vs. RCUS: 80%
Market capitalization -- CDIO: $5.99M vs. RCUS: $2.45B
CDIO [@Biotechnology] is valued at $5.99M. RCUS’s [@Biotechnology] market capitalization is $2.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDIO’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • CDIO’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, RCUS is a better buy in the long-term than CDIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDIO’s TA Score shows that 3 TA indicator(s) are bullish while RCUS’s TA Score has 2 bullish TA indicator(s).

  • CDIO’s TA Score: 3 bullish, 6 bearish.
  • RCUS’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CDIO is a better buy in the short-term than RCUS.

Price Growth

CDIO (@Biotechnology) experienced а -8.60% price change this week, while RCUS (@Biotechnology) price change was +1.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Reported Earning Dates

RCUS is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($2.45B) has a higher market cap than CDIO($6M). RCUS YTD gains are higher at: 32.908 vs. CDIO (-87.641). CDIO has higher annual earnings (EBITDA): -5.85M vs. RCUS (-282M). RCUS has more cash in the bank: 911M vs. CDIO (7.97M). CDIO has less debt than RCUS: CDIO (546K) vs RCUS (109M). RCUS has higher revenues than CDIO: RCUS (262M) vs CDIO (19.5K).
CDIORCUSCDIO / RCUS
Capitalization6M2.45B0%
EBITDA-5.85M-282M2%
Gain YTD-87.64132.908-266%
P/E RatioN/AN/A-
Revenue19.5K262M0%
Total Cash7.97M911M1%
Total Debt546K109M1%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDIORCUS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend about 1 month ago
69%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CDIO
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIGFX46.52-0.40
-0.85%
American Funds Intl Gr and Inc R5
TBLRX12.91-0.15
-1.15%
Transamerica Balanced II R
ISIPX19.99-0.33
-1.62%
Voya US Stock Index Port S2
SPXKX84.39-1.41
-1.64%
Shelton S&P 500 Index K
IAXAX7.80-0.20
-2.50%
VY® T. Rowe Price Divers Mid Cap Gr A

CDIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDIO has been loosely correlated with KRRO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CDIO jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDIO
1D Price
Change %
CDIO100%
-9.09%
KRRO - CDIO
35%
Loosely correlated
-79.31%
TARA - CDIO
31%
Poorly correlated
-0.57%
JAGX - CDIO
29%
Poorly correlated
-2.86%
RCUS - CDIO
26%
Poorly correlated
-1.05%
ATOS - CDIO
26%
Poorly correlated
-1.30%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-1.05%
XNCR - RCUS
54%
Loosely correlated
-2.78%
IDYA - RCUS
51%
Loosely correlated
-0.41%
IMNM - RCUS
49%
Loosely correlated
-5.28%
APGE - RCUS
48%
Loosely correlated
-0.21%
SYRE - RCUS
48%
Loosely correlated
-3.41%
More